The use of a new HMGCOA reductase inhibitor in the treatment of dyslipidaemic hypertensive
Professor Lau, Chu Pak (Principal investigator)
Dr Li (Co-Investigator)
Dr Tai Yau Ting (Co-Investigator)
Other Funding Scheme
To evaluate lovastatin in addition to dietary treatment in the control of abnormal lipid profile in this subset of patient.